Adaptimmune Therapeutics plc
ADAP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$48 | -$71 | -$18 |
| Dep. & Amort. | $3 | $2 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $5 | $3 |
| Change in WC | -$8 | -$21 | $26 | -$46 |
| Other Non-Cash | -$1 | -$1 | $3 | $3 |
| Operating Cash Flow | -$35 | -$67 | -$34 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$35 | -$66 |
| Inv. Sales/Matur. | $19 | $58 | $44 | $0 |
| Other Inv. Act. | $0 | -$17 | -$0 | -$0 |
| Investing Cash Flow | $18 | $41 | $8 | -$66 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$26 | -$25 | $25 |
| Stock Issued | $2 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $54 | -$0 |
| Financing Cash Flow | $2 | -$25 | $0 | $25 |
| Forex Effect | -$1 | $1 | -$0 | $0 |
| Net Chg. in Cash | -$15 | -$50 | -$26 | -$95 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43 | $93 | $119 | $215 |
| End Cash | $28 | $43 | $93 | $119 |
| Free Cash Flow | -$35 | -$67 | -$35 | -$55 |